Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T-cells for the treatment of Hyper IgM1.
EMBO J
; 42(23): e114188, 2023 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-37916874
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CRISPR-Cas Systems
/
Gene Editing
Limits:
Humans
Language:
En
Journal:
EMBO J
Year:
2023
Type:
Article
Affiliation country:
Italy